{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1206.17","meta":{"versionId":"5","lastUpdated":"2020-04-28T01:00:20.000-04:00"},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <h2>Coagulation Disorder Conditions</h2>\n      <p>This value set includes codes from the following code systems:</p>\n      <ul>\n        <li>Include these codes as defined in \n          <code>http://hl7.org/fhir/sid/icd-10-cm</code>\n          <table class=\"none\">\n            <tr>\n              <td>\n                <b>Code</b>\n              </td>\n              <td>\n                <b>Display</b>\n              </td>\n            </tr>\n            <tr>\n              <td>D61.09</td>\n              <td>Other constitutional aplastic anemia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D61.1</td>\n              <td>Drug-induced aplastic anemia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D61.3</td>\n              <td>Idiopathic aplastic anemia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D61.810</td>\n              <td>Antineoplastic chemotherapy induced pancytopenia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D61.811</td>\n              <td>Other drug-induced pancytopenia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D61.818</td>\n              <td>Other pancytopenia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D61.82</td>\n              <td>Myelophthisis</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D61.89</td>\n              <td>Other specified aplastic anemias and other bone marrow failure syndromes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D61.9</td>\n              <td>Aplastic anemia, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D65</td>\n              <td>Disseminated intravascular coagulation [defibrination syndrome]</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D66</td>\n              <td>Hereditary factor VIII deficiency</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D67</td>\n              <td>Hereditary factor IX deficiency</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.0</td>\n              <td>Von Willebrand's disease</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.1</td>\n              <td>Hereditary factor XI deficiency</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.2</td>\n              <td>Hereditary deficiency of other clotting factors</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.311</td>\n              <td>Acquired hemophilia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.312</td>\n              <td>Antiphospholipid antibody with hemorrhagic disorder</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.318</td>\n              <td>Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.32</td>\n              <td>Hemorrhagic disorder due to extrinsic circulating anticoagulants</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.4</td>\n              <td>Acquired coagulation factor deficiency</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.8</td>\n              <td>Other specified coagulation defects</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.9</td>\n              <td>Coagulation defect, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D69.1</td>\n              <td>Qualitative platelet defects</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D69.3</td>\n              <td>Immune thrombocytopenic purpura</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D69.41</td>\n              <td>Evans syndrome</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D69.42</td>\n              <td>Congenital and hereditary thrombocytopenia purpura</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D69.49</td>\n              <td>Other primary thrombocytopenia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D69.51</td>\n              <td>Posttransfusion purpura</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D69.6</td>\n              <td>Thrombocytopenia, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D69.8</td>\n              <td>Other specified hemorrhagic conditions</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D69.9</td>\n              <td>Hemorrhagic condition, unspecified</td>\n              <td/>\n            </tr>\n          </table>\n        </li>\n      </ul>\n    </div>"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.17","version":"20200428","name":"Coagulation Disorder Conditions","status":"active","date":"2020-04-28T01:00:20-04:00","publisher":"Brigham and Womenâ€™s Hospital Steward","compose":{"include":[{"system":"http://hl7.org/fhir/sid/icd-10-cm","concept":[{"code":"D61.09","display":"Other constitutional aplastic anemia"},{"code":"D61.1","display":"Drug-induced aplastic anemia"},{"code":"D61.3","display":"Idiopathic aplastic anemia"},{"code":"D61.810","display":"Antineoplastic chemotherapy induced pancytopenia"},{"code":"D61.811","display":"Other drug-induced pancytopenia"},{"code":"D61.818","display":"Other pancytopenia"},{"code":"D61.82","display":"Myelophthisis"},{"code":"D61.89","display":"Other specified aplastic anemias and other bone marrow failure syndromes"},{"code":"D61.9","display":"Aplastic anemia, unspecified"},{"code":"D65","display":"Disseminated intravascular coagulation [defibrination syndrome]"},{"code":"D66","display":"Hereditary factor VIII deficiency"},{"code":"D67","display":"Hereditary factor IX deficiency"},{"code":"D68.0","display":"Von Willebrand's disease"},{"code":"D68.1","display":"Hereditary factor XI deficiency"},{"code":"D68.2","display":"Hereditary deficiency of other clotting factors"},{"code":"D68.311","display":"Acquired hemophilia"},{"code":"D68.312","display":"Antiphospholipid antibody with hemorrhagic disorder"},{"code":"D68.318","display":"Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors"},{"code":"D68.32","display":"Hemorrhagic disorder due to extrinsic circulating anticoagulants"},{"code":"D68.4","display":"Acquired coagulation factor deficiency"},{"code":"D68.8","display":"Other specified coagulation defects"},{"code":"D68.9","display":"Coagulation defect, unspecified"},{"code":"D69.1","display":"Qualitative platelet defects"},{"code":"D69.3","display":"Immune thrombocytopenic purpura"},{"code":"D69.41","display":"Evans syndrome"},{"code":"D69.42","display":"Congenital and hereditary thrombocytopenia purpura"},{"code":"D69.49","display":"Other primary thrombocytopenia"},{"code":"D69.51","display":"Posttransfusion purpura"},{"code":"D69.6","display":"Thrombocytopenia, unspecified"},{"code":"D69.8","display":"Other specified hemorrhagic conditions"},{"code":"D69.9","display":"Hemorrhagic condition, unspecified"}]}]}}